Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Edgewise Therapeutics, Inc. | StockGist | StockGist

Companies
EWTX
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings EWTXSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Edgewise Therapeutics, Inc.

Filed Feb 17, 2026

Accepted Feb 16, 2026, 7:00 PM ET

CIK 0001710072

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

105,868,434

Reporting Person

Edgewise Therapeutics, Inc.

Person Type

PN

CUSIP: 28036F105

Amendment History

8 filings

SCHEDULE 13G
Original
Feb 21, 20250000950170-25-025021
SCHEDULE 13G/A
Amendment 1
May 14, 20250001274173-25-000160
SCHEDULE 13G/A
Amendment 2
May 15, 20250000950170-25-072730
SCHEDULE 13G/A
Amendment 3
Jul 17, 20250002052113-25-003023
SCHEDULE 13G/A
Amendment 4
Aug 14, 20250000950170-25-108936
SCHEDULE 13G/A
Amendment 5
Aug 14, 20250001274173-25-000244
SCHEDULE 13G/A
Amendment 6
Aug 14, 20250001104659-25-078659
SCHEDULE 13G/A
Amendment 7
Latest
Viewing
Feb 17, 20260001104659-26-016362

Key Facts

Shares Owned

105,868,434

Recent Filings

Edgewise Therapeutics, Inc.1 months ago

Edgewise Therapeutics, Inc.1 months ago

Edgewise Therapeutics, Inc.4 months ago

Edgewise Therapeutics, Inc.4 months ago

Edgewise Therapeutics, Inc.4 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice